CA51372-2B - 0x0000000000007105

Male & Females of Non-Childbearing Potential

Canvas

* Stipend may pay up to reflected amount.
Start Date: 
October 12, 2026 - 7:00am
End Date: 
November 14, 2026 - 2:10pm

Study Details

Study Number: CA51372
Group Number: 2B
Study Requirement: Healthy Normal Male and Female
Stipend: up to $4,500.00

Study Criteria

Age: 18 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to improve motor function in patients with muscular dystrophy.
Route of Administration: Oral
Blood Draws: 19

Study Schedule

Schedule Type: Short Term
Study Length: 5 Night Stay & 2 Phone Calls

Screening Dates:

Event Day Event Date
Monday 9/28/2026

Doctor Exam Dates:

Event Day Event Date
Monday 9/28/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 10/12/2026 7:00:00 AM Saturday 10/17/2026 11:30:00 AM 6 Phoenix
Check-In Monday 10/12/2026 11:10:00 AM Sunday 10/18/2026 11:35:00 AM 7 Phoenix
Check-In Monday 10/12/2026 11:15:00 AM Monday 10/19/2026 11:40:00 AM 8 Phoenix
Phone participant Thursday 10/22/2026 2:00:00 PM 6 Phoenix
Phone participant Friday 10/23/2026 2:05:00 PM 7 Phoenix
Phone participant Saturday 10/24/2026 2:10:00 PM 8 Phoenix
Phone participant Thursday 11/12/2026 2:00:00 PM 6 Phoenix
Phone participant Friday 11/13/2026 2:05:00 PM 7 Phoenix
Phone participant Saturday 11/14/2026 2:10:00 PM 8 Phoenix